Summary of Study ST004028
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002520. The data can be accessed directly via it's Project DOI: 10.21228/M8WZ6W This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST004028 |
| Study Title | Bacterial consumption of nutrients in blood environment |
| Study Summary | Staphylococcus aureus adapts to diverse host environments during infection. Here, the authors study how S. aureus adapts in the blood environment by studying which nutrients are consumed by methicillin-resistant S. aureus upon inoculation into human whole blood or tryptic soy broth (TSB) media as a control. For this, USA300 is inoculated into human whole blood or TSB for up to 36 h, during which the supernatant is collected and measured by LC-MS for the amounts of glucose and lactate remaining after consumption by the bacteria. Additionally, USA300 is cultured in human whole blood up to 24 h, during which the supernatant is collected for the measurement of amino acid consumption by the bacteria in blood. Lastly, USA300 is cultured in whole blood or TSB for up to 24 h, during which the bacterial cells are collected for the measurement of the intracellular bacillithiol produced by the bacterial cells during growth in blood or TSB. Our results show that glucose and lactate are simultaneously consumed in human whole blood, while in TSB, glucose is consumed before the consumption of lactate. S. aureus exhibited the ability to adapt its mode of catabolic repression and shifted to a simultaneous mode only in the blood environment, which conferred a fitness advantage. Additionally, we observed that S. aureus actively consumed all amino acids except cystine. Such accumulation of cystine was associated with the increased intracellular bacillithiol when USA300 was cultured in the blood environment. These results indicate that to survive in blood, S. aureus depends on genes related to response to oxidative stress, including those associated with bacterial thiol synthesis. In sum, our results indicate that S. aureus adjusts its metabolism to better adapt to the extracellular host environment, allowing for more efficient utilization of available carbon sources and response to oxidative stress. |
| Institute | Sungkyunkwan University |
| Last Name | Lee |
| First Name | Wonsik |
| Address | 2066, Seobu-ro, Jangan-gu, Suwon-si, South Korea |
| manager2.leelab@gmail.com | |
| Phone | 010-4686-0544 |
| Submit Date | 2025-06-30 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | mzML |
| Analysis Type Detail | LC-MS |
| Release Date | 2025-07-09 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR002520 |
| Project DOI: | doi: 10.21228/M8WZ6W |
| Project Title: | Environmental cues in different host niches shape the survival fitness of Staphylococcus aureus |
| Project Summary: | The ability of Staphylococcus aureus to adapt and thrive in diverse host niches adds to the challenge in combating this ubiquitous pathogen. While extensive research has been pursued on the adaptive mechanisms of methicillin-resistant S. aureus (MRSA) in various infection models, a comprehensive analysis of its fitness across different host niches is lacking. In this study, we employ transposon sequencing to analyze the adaptive strategies of MRSA in various infection niches. Our analysis encompasses a cell model that mimics an intracellular niche, human blood, which represents a major extracellular environment as well as a major intermediary route encountered by bacteria during systemic infection, and a murine sepsis model that recapitulates intra-organ environments. Our findings reveal substantial differences in the genetic determinants essential for bacterial survival in intracellular and blood environments. Moreover, we show that each organ imposes unique growth constraints, thus fostering heterogeneity within the mutant population that can enter and survive in each organ of the male mouse. By comparing genes important for survival across all examined host environments, we identify 27 core genes that represent potential therapeutic targets for treating S. aureus infections. Additionally, our findings aid in understanding how bacteria adapt to diverse host environments. |
| Institute: | Sungkyunkwan University |
| Last Name: | Lee |
| First Name: | Wonsik |
| Address: | 2066, Seobu-ro, Jangan-gu, Suwon-si, South Korea |
| Email: | manager2.leelab@gmail.com |
| Phone: | 010-4686-0544 |
Subject:
| Subject ID: | SU004174 |
| Subject Type: | Bacteria |
| Subject Species: | Staphylococcus aureus |
| Taxonomy ID: | 1280 |
Factors:
Subject type: Bacteria; Subject species: Staphylococcus aureus (Factor headings shown in green)
| mb_sample_id | local_sample_id | Growth_Medium | Sample source | Incubation_Time_(h) |
|---|---|---|---|---|
| SA464592 | Blood_bac_12_4 | Blood | Bacterial cells | 12 |
| SA464593 | Blood_bac_12_2 | Blood | Bacterial cells | 12 |
| SA464594 | Blood_bac_12_1 | Blood | Bacterial cells | 12 |
| SA464595 | Blood_bac_24_4 | Blood | Bacterial cells | 24 |
| SA464596 | Blood_bac_24_3 | Blood | Bacterial cells | 24 |
| SA464597 | Blood_bac_24_2 | Blood | Bacterial cells | 24 |
| SA464598 | Blood_GL_0_4 | Blood | Plasma | 0 |
| SA464599 | Blood_AA_0_3 | Blood | Plasma | 0 |
| SA464600 | Blood_AA_0_2 | Blood | Plasma | 0 |
| SA464601 | Blood_AA_0_1 | Blood | Plasma | 0 |
| SA464602 | Blood_GL_0_3 | Blood | Plasma | 0 |
| SA464603 | Blood_GL_0_5 | Blood | Plasma | 0 |
| SA464604 | Blood_GL_12_1 | Blood | Plasma | 12 |
| SA464605 | Blood_GL_12_5 | Blood | Plasma | 12 |
| SA464606 | Blood_AA_12_5 | Blood | Plasma | 12 |
| SA464607 | Blood_AA_12_3 | Blood | Plasma | 12 |
| SA464608 | Blood_AA_12_2 | Blood | Plasma | 12 |
| SA464609 | Blood_GL_12_3 | Blood | Plasma | 12 |
| SA464610 | Blood_AA_24_5 | Blood | Plasma | 24 |
| SA464611 | Blood_AA_24_3 | Blood | Plasma | 24 |
| SA464612 | Blood_AA_24_1 | Blood | Plasma | 24 |
| SA464613 | Blood_GL_24_4 | Blood | Plasma | 24 |
| SA464614 | Blood_GL_24_3 | Blood | Plasma | 24 |
| SA464615 | Blood_GL_24_2 | Blood | Plasma | 24 |
| SA464616 | Blood_GL_3_2 | Blood | Plasma | 3 |
| SA464617 | Blood_GL_3_3 | Blood | Plasma | 3 |
| SA464618 | Blood_GL_3_5 | Blood | Plasma | 3 |
| SA464619 | Blood_GL_36_4 | Blood | Plasma | 36 |
| SA464620 | Blood_GL_36_2 | Blood | Plasma | 36 |
| SA464621 | Blood_GL_36_1 | Blood | Plasma | 36 |
| SA464622 | Blood_GL_6_4 | Blood | Plasma | 6 |
| SA464623 | Blood_GL_6_3 | Blood | Plasma | 6 |
| SA464624 | Blood_GL_6_5 | Blood | Plasma | 6 |
| SA464625 | Blood_AA_9_3 | Blood | Plasma | 9 |
| SA464626 | Blood_GL_9_5 | Blood | Plasma | 9 |
| SA464627 | Blood_GL_9_1 | Blood | Plasma | 9 |
| SA464628 | Blood_AA_9_5 | Blood | Plasma | 9 |
| SA464629 | Blood_GL_9_2 | Blood | Plasma | 9 |
| SA464630 | Blood_AA_9_2 | Blood | Plasma | 9 |
| SA464631 | TSB_Con_0_3 | TSB | Bacterial cells | 0 |
| SA464632 | TSB_Con_0_1 | TSB | Bacterial cells | 0 |
| SA464633 | TSB_Con_0_2 | TSB | Bacterial cells | 0 |
| SA464634 | TSB_bac_12_1 | TSB | Bacterial cells | 12 |
| SA464635 | TSB_bac_12_3 | TSB | Bacterial cells | 12 |
| SA464636 | TSB_bac_12_2 | TSB | Bacterial cells | 12 |
| SA464637 | TSB_bac_24_1 | TSB | Bacterial cells | 24 |
| SA464638 | TSB_bac_24_3 | TSB | Bacterial cells | 24 |
| SA464639 | TSB_bac_24_2 | TSB | Bacterial cells | 24 |
| SA464640 | TSB_GL_0_5 | TSB | Supernatant | 0 |
| SA464641 | TSB_GL_0_2 | TSB | Supernatant | 0 |
| SA464642 | TSB_GL_0_3 | TSB | Supernatant | 0 |
| SA464643 | TSB_GL_12_5 | TSB | Supernatant | 12 |
| SA464644 | TSB_GL_12_3 | TSB | Supernatant | 12 |
| SA464645 | TSB_GL_12_4 | TSB | Supernatant | 12 |
| SA464646 | TSB_GL_24_5 | TSB | Supernatant | 24 |
| SA464647 | TSB_GL_24_4 | TSB | Supernatant | 24 |
| SA464648 | TSB_GL_24_3 | TSB | Supernatant | 24 |
| SA464649 | TSB_GL_3_5 | TSB | Supernatant | 3 |
| SA464650 | TSB_GL_3_3 | TSB | Supernatant | 3 |
| SA464651 | TSB_GL_3_4 | TSB | Supernatant | 3 |
| SA464652 | TSB_GL_36_4 | TSB | Supernatant | 36 |
| SA464653 | TSB_GL_36_5 | TSB | Supernatant | 36 |
| SA464654 | TSB_GL_36_1 | TSB | Supernatant | 36 |
| SA464655 | TSB_GL_6_4 | TSB | Supernatant | 6 |
| SA464656 | TSB_GL_6_3 | TSB | Supernatant | 6 |
| SA464657 | TSB_GL_6_2 | TSB | Supernatant | 6 |
| SA464658 | TSB_GL_9_2 | TSB | Supernatant | 9 |
| SA464659 | TSB_GL_9_4 | TSB | Supernatant | 9 |
| SA464660 | TSB_GL_9_3 | TSB | Supernatant | 9 |
| Showing results 1 to 69 of 69 |
Collection:
| Collection ID: | CO004167 |
| Collection Summary: | Staphylococcus aureus has been cultured in tryptic soy broth (TSB) media or blood for various time points up to 36 hours. At designated time points, supernatant was collected for the measurement of glucose/lactate or amino acid consumption. For the measurement of bacillithiol production, bacterial cells were collected by centrifugation and prepared for mass spectrometric analysis. |
| Sample Type: | Plasma, Supernatant, Bacterial cells |
Treatment:
| Treatment ID: | TR004183 |
| Treatment Summary: | Staphylococcus aureus has been grown in TSB and human whole blood. The samples were incubated at 37 ºC, with shaking at 150 rpm for various time points from 3 to 36 h. For determination of bacterial bacillithiol levels, USA300 was inoculated into whole blood or TSB at an OD600=0.02 with shaking at 150 rpm at 37 ºC. At 9, 12, and 24 h post-inoculation, samples were centrifuged at 4 ºC, 6,010 x g for 6 min for the collection of bacterial cells. Bacterial cells collected at a log phase (OD600=0.5) were defined as a 0 h sample. The resulting pellet was quenched by the addition of quenching buffer (40:40:20; Acetonitrile:Methanol:Water). |
Sample Preparation:
| Sampleprep ID: | SP004180 |
| Sampleprep Summary: | At the designated time points, whole blood or TSB samples were centrifuged for 2 min at 13,523 x g, 4 ºC. The supernatant was vortexed and mixed with cold methanol (v/v ratio 1:2). All samples mixed with methanol were centrifuged for 2 minutes at 4 ºC, 15,871 x g. Supernatant was added to Spin-X centrifuge tubes (Corning Inc., Corning, NY) and centrifuged at 4 ºC, 15,871 x g one more time. Bacterial cells were lysed by mechanical disruption using 0.1 mm glass beads and a precellys homogenizer (Bertin Technologies, Montigny-le-Bretonneux, France) with 12 cycles of 10,000 rpm, 30 sec cycle. Samples were placed on ice in-between each cycle for the prevention of protein degradation. Lysates were centrifuged at 4 ºC, 15,871 x g for 5 min, after which supernatant was added to Spin-X centrifuge tubes (Corning Inc.) and centrifuged at 4 ºC, 15,871 x g one more time. |
Chromatography:
| Chromatography ID: | CH005057 |
| Instrument Name: | Agilent 1290 Infinity II |
| Column Name: | Cogent Diamond Hydride (150 x 2.1mm, 4um, 100A) |
| Column Temperature: | 25 |
| Flow Gradient: | 0–2 min, 85% B; 3–5 min, 80% B; 6–7 min, 75% B; 8–9 min, 70% B; 10–11.1 min, 50% B; 11.1–14 min 20% B; 14.1–24 min 5% B followed by a 10 min re-equilibration period at 85% B |
| Flow Rate: | 0.4 mL/min |
| Solvent A: | 100% water; 0.2% formic acid |
| Solvent B: | 100% acetonitrile; 0.2% formic acid |
| Chromatography Type: | HILIC |
Analysis:
| Analysis ID: | AN006655 |
| Analysis Type: | MS |
| Chromatography ID: | CH005057 |
| Num Factors: | 19 |
| Num Metabolites: | 18 |
| Units: | abundance |
| Analysis ID: | AN006656 |
| Analysis Type: | MS |
| Chromatography ID: | CH005057 |
| Num Factors: | 19 |
| Num Metabolites: | 2 |
| Units: | abundance |